Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Completed
Conditions studied: Bladder Cancer, Kidney Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
In brief
RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of the urothelium and in healthy participants.
Key facts
- Study ID
- NCT00900276
- Run by
- Wake Forest University Health Sciences
- People needed
- 5
- Starts
- 2006-06-01
- Expected to finish
- 2011-04-01
- Last updated by the study team
- 2018-07-05
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: accepted.
Where it is running
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.